Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On April 19, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 9,601 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $0.7506, with individual transactions ranging from $0.7460 to $0.7562.
- Following the transaction, Brainard directly owns 802,935 shares of Allovir common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. The CEO sold shares to cover taxes, which is a normal part of executive compensation. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine transaction for executives who receive stock as part of their compensation. It is common for them to sell a portion of their shares to cover the taxes associated with the vesting of those shares.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Date of stock sale transaction. |
| 04/23/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.